Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Get research updatesThis study is not yet recruiting. It is testing ketamine Infusion for PTSD.
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Then choose your country and confirm availability with each study site.
This summary needs review. Please check the official study record and contact the research team for details.
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)This record does not confirm open recruitment. We can help you understand it and explore other studies.
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)No specific site is confirmed in the available information. Check the official source for locations and remote participation.
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Confirm the location and whether remote participation is possible with the research team.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Based on the public registry summary, this study is trying to understand: The goal of this pilot study is to evaluate the feasibility of conducting a clinical trial assessing if ketamine infusions combined to mindfulness therapy works better than psychotherapy alone to treat chronic pain and PTSD in adults living with both conditions. The objectives. The study team can confirm the exact objective and what it means for you.
This appears to be a medication / drug study involving Ketamine Infusion, Mindfulness-based cognitive therapy. Phase 1 studies usually focus mainly on safety, tolerability, dosage, and side effects. They often involve healthy volunteers, but not always. Some Phase 1 studies include people living with the target condition.
This study may concern people with ptsd; age range: From 18 Years to 64 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
You may need to take a study treatment and have regular medical follow-up.
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
The likely practical burden appears high. Things to check include multiple visits or assessments, medical follow-up. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.
This study is sponsored by Queen's University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me